Global Antibody and Recombinant Protein CDMO Market Size To Worth USD 45.7 Billion by 2033 | CAGR of 10.79%
Category: HealthcareGlobal Antibody and Recombinant Protein CDMO Market Size To Worth USD 45.7 Billion By 2033
According to a research report published by Spherical Insights & Consulting, the Global Antibody and Recombinant Protein CDMO Market Size is to Grow from USD 16.4 Billion in 2023 to USD 45.7 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 10.79% during the projected period.
Get more details on this report -
Browse key industry insights spread across 210 pages with 110 Market data tables and figures & charts from the report on the "Global Antibody and Recombinant Protein CDMO Market Size, Share, and COVID-19 Impact Analysis, By Type (Antibody CDMO and Recombinant Protein CDMO), By Application (Pharmaceutical Company, Biotechnology Company, and Generic Company), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here:https://www.sphericalinsights.com/reports/antibody-and-recombinant-protein-cdmo-market
The antibody and recombinant protein industry is a branch of the pharmaceutical industry that focuses on developing and commercializing recombinant proteins and antibodies. The rising need for biological products in the pharmaceutical industry, together with advances in biotechnology and research, is expected to drive the growth of the antibody and recombinant protein CDMO market. Antibody and recombinant protein development and manufacturing are increasingly being outsourced to specialist CDMOs in order to cut costs and improve efficiency, which is projected to drive growth in the antibody and recombinant protein CDMO market. However, the high initial cost could restrict the market growth.
The antibody CDMO segment holds the biggest market share during the projection period.
Based on the type, the global antibody and recombinant protein CDMO market is categorized into antibody CDMO, and recombinant protein CDMO. Among these, the antibody CDMO segment holds the biggest market share during the projection period. CDMOs can offer a distinct set of skills, such as efficient and scalable production, which is required in light of rising scientific expenditure and the demand for breakthrough medicinal therapies. Furthermore, developments in bioprocessing technology, such as continuous manufacturing and disposable systems, are increasing antibody production efficiency and cost.
The biotechnology company category holds the largest market share during the projection period.
Based on the application, the global antibody and recombinant protein CDMO market is categorized into pharmaceutical company, biotechnology company, and generic company. Among these, the biotechnology company category holds the largest market share during the projection period. The growing need for biologics, particularly recombinant proteins and monoclonal antibodies, which are important for creating new medicines, fuels the growth of biotechnology companies. Biotechnology businesses are driving this growth, utilizing cutting-edge technology and specialized knowledge to meet the demanding requirements of biologic production.
North America is having the biggest share of the global antibody and recombinant protein CDMO market over the forecast period.
Get more details on this report -
North America is having the biggest share of the global antibody and recombinant protein CDMO market over the forecast period. The North American antibody and recombinant protein CDMO market is expected to have the greatest revenue share in the near future. The United States and Canada are the two major North American countries driving market expansion. The existence of big biotechnology and pharmaceutical businesses, as well as an established healthcare system, are significant drivers of market growth in this region. Personalized medicine is in high demand, and investments in healthcare infrastructure are growing.
Asia-Pacific is predicted to grow fastest pace throughout the forecast period. The region is seeing an increase in healthcare infrastructure spending, which correlates with the increased need for personalized medication. The sector is growing as a result of the region's increased focus on research and development projects.
Major vendors in the global antibody and recombinant protein CDMO market include, Wuxibiologics, Cerbios-Pharma SA, Genscriptprobio, Vetter, Etinpro (Beijing) Co. Boehringer Ingelheim BioXcellence, Eurogentec, HJB, Bibo Pharma, MabPlex International, Lonza, 3SBio Inc, Porton, Catalent, Bioinnobio, Thousand Oaks Biopharmaceuticals, Goodwin Biotechnology, Salipro Biotech, and Others.
Recent Developments
- In October 2023, Salipro Biotech and Icosagen announced the initiation of a multi-target partnership to develop and characterize monoclonal antibodies against several GPCRs and SLC transporters.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global antibody and recombinant protein CDMO market based on the below-mentioned segments:
Global Antibody and Recombinant Protein CDMO Market, By Type
- Antibody CDMO
- Recombinant Protein CDMO
Global Antibody and Recombinant Protein CDMO Market, By Application
- Pharmaceutical Company
- Biotechnology Company
- Generic Company
Global Antibody and Recombinant Protein CDMO Market, By Regional
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- Uk
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?